Citation

84 FR 28063

Multiple canonical documents share this first-page citation.

Prospective Grant of an Exclusive Patent License: Development and Commercialization of Cell Therapies for Cancer Monday, June 17, 2019 84 FR 28063
Prospective Grant of Exclusive Patent License: Lutetium-177 Radiotherapeutics Against Somatostatin-Receptor Expressing Neuroendocrine Tumors Monday, June 17, 2019 84 FR 28063